Search
Showing results for "Childhood interstitial lung disease "
Tom Snelling BMBS DTMH GDipClinEpid PhD FRACP Head, Infectious Disease Implementation Research 08 6319 1817 tom.snelling@thekids.org.au Head,
Safe, highly curative, short course, direct acting antiviral (DAA) therapies are now available to treat chronic hepatitis C. DAA therapy is freely available to all adults chronically infected with the hepatitis C virus (HCV) in Australia. If left untreated, hepatitis C may lead to progressive hepatic fibrosis, cirrhosis and hepatocellular carcinoma.
This narrative review describes the evolution, range and relative strengths and weaknesses of endpoints used in late phase trials
The Sharing Knowledge About Immunisation project aims to develop effective communication tools to support primary health care providers' consultations with parents
Participants demonstrated a good understanding of safe prescribing and antimicrobial stewardship
The program was associated with a substantial decline in rotavirus attributable non-admitted AGE presentations to ED among children aged <5 years.
This study aimed to examine the uptake of influenza vaccination amongst a cohort of Australian children and factors associated with vaccine acceptance.
It has been hypothesized that vitamin D deficiency (VDD) contributes to the development of food sensitization (FS) and then food allergy.
The greatest threat to children’s health in the future is environmental change, including climate change. The Future Child Health project aims to quantify how current and future environmental changes affect child health.
Discover how our breakthroughs are helping kids with diabetes live longer, safer lives.